Intracranial Hemorrhage, Outcome, and Mortality After Intra-Arterial Therapy for Acute Ischemic Stroke in Patients Under Oral Anticoagulants
Publisher DOI
PubMed ID
21980194
Abstract
Use of intravenous tissue-type plasminogen activator (IV tPA) for acute ischemic stroke is restricted to patients with an international normalized ratio (INR) less than 1.7. However, a recent study showed increased risk of symptomatic intracranial hemorrhage after IV tPA use in patients with oral anticoagulants (OAC) even with an INR less than 1.7. The present study assessed the risk of symptomatic intracranial hemorrhage, clinical outcome, and mortality after intra-arterial therapy (IAT) in patients with and without previous use of OAC.
Date Issued
2011
Publication Type
Article
Subject(s)
Language(s)
en
Author(s)
Jung, Simon |
Journal
Stroke
Publisher
Lippincott Williams & Wilkins
ISSN
0039-2499
Access(Rights)
metadata.only